Pharmaco - Press Releases

Date	Title	Company
11-Sep-2023	Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company	Epigenomics AG
11-Sep-2023	Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia	Biophytis
08-Sep-2023	Moberg Pharma resolves a directed issue of units to guarantors in connection with the completed rights issue	Moberg Pharma AB
08-Sep-2023	aap offers its shareholders a EUR 2.7 million mandatory convertible bond; subscription commitments of around 83% already received; accompanying restructuring measures in preparation	aap Implantate AG
08-Sep-2023	Independent pharmacy owner Olivier Picard provides Wegovy to the first patient in the UK with the support of Pharmadoctor	Pharmadoctor
08-Sep-2023	ABPI response: UK joins Horizon Europe	ABPI
08-Sep-2023	AMO Pharma Announces Affirming Data from REACH-CDM Clinical Trial for AMO-02 in Treatment of Myotonic Dystrophy	AMO Pharma
08-Sep-2023	Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update	Adrenomed AG
08-Sep-2023	Dominik Arnold to become new CEO of the COLTENE Group	COLTENE Holding AG
07-Sep-2023	Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer	Pleco Therapeutics
07-Sep-2023	MPH Health Care AG: Half-year result 2023	MPH Health Care AG
07-Sep-2023	Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo	Biotest AG
07-Sep-2023	Abivax provides business and operational update	ABIVAX
06-Sep-2023	Engitix Announces Appointment of Christopher Stevenson Ph.D., as Chief Scientific Officer	Engitix Ltd
06-Sep-2023	Novel Molecular Design for Enhanced Efficacy and Safety in Radiotheranostics	Chiba University, Japan
06-Sep-2023	Bloomsbury Genetic Therapies Announces New Program in Parkinson’s Disease	Bloomsbury Genetic Therapies Limited
06-Sep-2023	AI in BioMed Economy Surpasses $2.5 Trillion in 2023, Set to Reach $6 Trillion by 2027	Global AI Ecosystem
06-Sep-2023	Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer	Pleco Therapeutics
06-Sep-2023	Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin® Ligand Discovery Using Cutting-Edge AI and Molecular Modeling Techniques	Navigo Proteins
06-Sep-2023	Vicore Pharma Announces Presentations at the European Respiratory Society (ERS) International Congress 2023	Vicore Pharma